Table 4.
Characteristics |
Total (N = 1782) N (%) |
Threatened but resolved risk of ATI (N = 730) n (%) |
Risk of imminent ATI (N = 917) n (%) |
Experienced ATI (N = 135) n (%) |
---|---|---|---|---|
No. days of ART reserve when PLHIV realized risk of ATI: Median (IQR) | 10 (6 to 15) | 10 (6 to 20) | 10 (7 to 15)a | 5 (0 to 14)b |
Strategies used to solve ATI | ||||
Disclosed HIV status and applied for permission to travel to an HIV clinic | 87 (4.88) | 42 (5.75) | 42 (4.58) | 3 (2.22) |
Pretended to have a disease other than HIV requiring urgent care | 862 (48.37) | 436 (59.73) | 374 (40.79) | 52 (38.52) |
Decided not to obtain ART to avoid disclosure of HIV status | 637 (35.75) | 80 (10.96) | 502 (54.74) | 55 (40.74) |
Otherc | 361 (20.26) | 199 (27.26) | 136 (14.83) | 26 (19.26) |
Barriers to obtaining ART from HIV clinics during COVID‐19 | ||||
Cumbersome administrative procedures | 911 (51.12) | 379 (51.92) | 463 (50.49) | 69 (51.11) |
Lockdown and travel restrictions | 1172 (65.77) | 449 (61.51) | 627 (68.38) | 96 (71.11) |
Fear of disclosing HIV status | 1379 (77.38) | 584 (80.00) | 696 (75.90) | 99 (73.33) |
Otherd | 192 (10.77) | 90 (12.33) | 86 (9.38) | 16 (11.85) |
Preferred way of obtaining additional ART during COVID‐19 | ||||
Mailed by one’s primary HIV clinic | 1418 (79.57) | 580 (79.45) | 731 (79.72) | 107 (79.26) |
Dispensed by a nearby HIV clinic other than one’s primary HIV clinic | 251 (14.09) | 100 (13.70) | 128 (13.96) | 23 (17.04) |
Purchased online and delivered by mail | 113 (6.34) | 50 (6.85) | 58 (6.32) | 5 (3.70) |
ART, antiretroviral therapy; ATI, antiretroviral therapy interruption; IQR, interquartile range; PLHIV, people living with HIV.
1 missing
1 missing
other includes violating travel restrictions to reach an HIV clinic and purchasing ART out of pocket
other includes insufficient ART supply at local clinics, suspension of postal and courier services and no response from local clinics.